By Simpson Global Media News Desk
Plateau State has an estimated tuberculosis burden of about 11,000 cases in 2026, with 2,047 patients identified and placed on treatment between July and September, according to a state health official who warned that insecurity, overcrowded displacement camps, stigma and shortages of essential medicines are complicating efforts to control the disease.
Yohanna Bot, monitoring and evaluation officer of the Plateau State Tuberculosis and Leprosy Control Programme, disclosed the figures at a media advocacy meeting on community-led monitoring of health services in Jos. He said the estimated burden was based on a prevalence rate of 219 cases per 100,000 people. The 11,000 figure is an estimate of the state's disease burden, while the 2,047 patients represent people identified and linked to treatment during the three-month reporting period. They should not be interpreted as two separate confirmed totals of newly diagnosed cases. (Premium Times, October 19, 2026; Vanguard)
Bot said the patients identified during the quarterly survey were receiving treatment at health facilities across the state. He nevertheless identified major obstacles to controlling tuberculosis, including delayed diagnosis caused by stigma and misconceptions, difficulty reaching displaced communities and gaps in the supply of anti-tuberculosis medicines.
He specifically highlighted challenges in Mangu, Jos South and Barkin Ladi local government areas, where insecurity has displaced residents and contributed to the establishment of camps for internally displaced persons. Overcrowded living conditions in such settings can increase the risk of airborne infections spreading, making access to screening, diagnosis and continuing treatment particularly important.
The state programme is prioritising community outreach and active screening in displacement camps and correctional centres to find people who may have tuberculosis and connect them with care. However, the reported medicine shortages raise questions about how reliably patients can access the full course of treatment they need.
The announcement places a spotlight on the work required to control a preventable and curable disease when public health services must operate amid insecurity, population movement, resource constraints and persistent misinformation.
What the 11,000 estimate means
The figure announced in Jos is an estimate of the tuberculosis burden in Plateau State, rather than confirmation that every person represented by the estimate has been individually diagnosed.
Bot said the estimate was based on a prevalence rate of 219 cases per 100,000 people. Prevalence is a measure used to estimate how widespread a disease is within a population. It differs from the number of patients newly diagnosed in a particular period, the number receiving treatment and the number of cases reported through health facilities.
This distinction matters when interpreting public health figures.
The estimate provides an indication of the scale of the challenge facing the state, while the 2,047 people identified between July and September show the results of case-finding and treatment-linkage activity during that quarter. The announcement does not establish that those 2,047 patients account for the entire estimated burden, nor does it provide a complete breakdown of how many people remain undiagnosed.
The difference between an estimated disease burden and cases detected through routine services is a major concern in tuberculosis control. People may have symptoms but not seek care, may not recognise the significance of their symptoms, or may face financial, geographical or social barriers to testing.
Others may approach health facilities but not complete the diagnostic process or may be difficult to follow up if they move between communities.
The World Health Organization explains that tuberculosis symptoms can develop gradually and remain mild for months, creating opportunities for delayed diagnosis. Some people with active disease may also have few noticeable symptoms, depending on the circumstances. (WHO tuberculosis fact sheet)
For Plateau State, closing the gap between the estimated burden and the number of people identified will require sustained screening, accessible diagnostic services, public awareness and a reliable pathway from diagnosis to treatment.
The latest figures are therefore important not simply because they indicate the scale of the problem, but because they raise questions about whether people who need care are being reached early enough.
How tuberculosis spreads
Tuberculosis, commonly called TB, is an infectious disease caused by bacteria. It most often affects the lungs, although it can also affect other parts of the body.
Pulmonary tuberculosis can spread through the air when a person with infectious disease releases bacteria into the surrounding air by coughing, sneezing, speaking or singing. People nearby may inhale the bacteria and become infected.
The likelihood of transmission depends on several factors, including the infectiousness of the person who has the disease, how close and how long people are together, the ventilation of the environment and whether appropriate infection-prevention measures are in place.
This is one reason overcrowding can complicate disease control. When many people share enclosed or poorly ventilated spaces, they may have more prolonged exposure to air containing infectious particles.
However, exposure does not mean that every infected person will immediately develop active tuberculosis. Some people have TB infection without symptoms and cannot transmit the disease. In some cases, the bacteria may later become active if the person's immune defences weaken.
The WHO says tuberculosis is both preventable and curable, but it remains a major cause of illness and death globally. Its 2026 fact sheet reports that an estimated 10.7 million people fell ill with TB worldwide in 2024, while approximately 1.23 million people died from the disease that year. (WHO, Tuberculosis, updated March 24, 2026)
These global figures provide context for Plateau State's announcement. They do not mean that the state's estimate can be directly compared with worldwide totals without considering population size, reporting methods and the distinction between prevalence and incidence.
For residents, the practical message is that tuberculosis requires timely diagnosis, appropriate treatment and measures to reduce exposure in settings where transmission may occur.
Recognising symptoms and seeking medical attention
Bot urged residents with symptoms suggestive of tuberculosis to seek medical evaluation at health facilities.
Common symptoms of active TB include a prolonged cough, chest pain, weakness, fatigue, unexplained weight loss, fever and night sweats. Some people may cough up blood. Symptoms can differ depending on whether the disease affects the lungs or another part of the body. (WHO tuberculosis fact sheet)
These symptoms are not exclusive to tuberculosis. Other infections and medical conditions can cause similar problems, so symptoms alone cannot establish a diagnosis.
A persistent cough, unexplained weight loss or other concerning symptoms should prompt medical assessment, particularly where a person has been in close contact with someone diagnosed with TB or has other factors that increase the risk of severe disease.
Seeking care early can help a patient receive appropriate testing and, where necessary, start treatment sooner. It can also help reduce the period during which infectious pulmonary TB may go undiagnosed.
The WHO recommends rapid diagnostic tests as initial tests for people with signs and symptoms of tuberculosis. Depending on the clinical situation and available services, health workers may request a sputum sample or use other appropriate diagnostic methods. Further tests may be needed to establish whether the disease is drug-resistant or affects parts of the body outside the lungs. (WHO tuberculosis fact sheet)
Residents should not assume that a cough is tuberculosis, but neither should they dismiss persistent symptoms or rely exclusively on traditional explanations without obtaining medical advice.
The state's concern about delayed diagnosis reflects the importance of making health services accessible and ensuring that people feel able to seek care without fear of humiliation or discrimination.
Stigma and misinformation remain barriers
Bot expressed concern that some residents still attribute tuberculosis to spiritual or ritual causes rather than seeking medical attention.
Such misconceptions can delay testing and treatment. When a disease is viewed primarily through the lens of blame, fear or spiritual punishment, an affected person may avoid discussing symptoms, conceal a diagnosis or turn to approaches that do not provide the medical care required.
This can have consequences for both the individual and the community. Delayed diagnosis may allow the disease to progress and, in the case of infectious pulmonary TB, may increase the period during which other people are exposed.
Public health education is therefore an important part of the response. Information needs to explain how tuberculosis spreads, what symptoms may occur, where people can obtain testing and why treatment should be followed as prescribed.
Messages should be delivered in languages and formats that residents understand, with opportunities for questions and confidential access to care.
Community leaders, health workers, educators, civil society organisations and local media can all help communicate accurate information. Their role is especially important in areas where access to reliable health information may be limited.
Education should also make clear that a tuberculosis diagnosis is not a reason to shame or isolate someone socially beyond the infection-prevention measures recommended by health professionals.
People affected by TB need appropriate medical care and practical support. Public hostility can make it harder for them to remain engaged with services and complete treatment.
A response that combines accurate information with respect for patients can encourage earlier testing and help prevent misinformation from undermining disease-control efforts.
Insecurity and displacement complicate case detection
The Plateau State programme identified insecurity and population displacement as major obstacles to tuberculosis control, particularly in Mangu, Jos South and Barkin Ladi.
Violence and insecurity can force families to leave their homes and settle in temporary accommodation or camps. Displacement may disrupt access to healthcare, interrupt medication schedules and separate patients from the facilities or health workers familiar with their treatment.
Families may also prioritise food, shelter, safety and other urgent needs, leaving less time or money for routine medical visits.
For tuberculosis programmes, these circumstances can make it harder to identify people with symptoms, carry out diagnostic tests, maintain treatment records and follow up with patients who relocate.
Crowded living arrangements may create additional transmission risks, especially when ventilation is inadequate and people spend extended periods in shared indoor spaces.
Bot said the state programme was prioritising community outreach and active screening in internally displaced persons' camps to identify people who may have TB and connect them to treatment. He also identified correctional centres as settings where outreach and screening were being prioritised. (Premium Times)
Such activities can help bring services closer to people who may struggle to visit a health facility.
For outreach to be effective, however, screening must be linked to reliable diagnosis, access to appropriate medicines and continued support for people who test positive. Identifying a possible case is only the first step in a process that must continue through treatment and follow-up.
Health workers also need safe access to affected communities, suitable equipment and coordination with organisations serving displaced people.
The situation in Plateau illustrates how public health programmes can be affected by challenges that extend beyond the health sector itself. Security, housing, transport and access to basic services can all influence whether residents are able to obtain care.
Why overcrowded camps need particular attention
The concern about overcrowded displacement camps is rooted in the way tuberculosis spreads.
When people live close together for extended periods, particularly in enclosed spaces with limited ventilation, infectious respiratory diseases may spread more readily. The risk depends on the conditions within the setting and the infectiousness of the person with TB; overcrowding does not mean that everyone in a camp will become infected.
Prevention measures can include identifying symptoms early, arranging prompt testing, ensuring adequate ventilation and connecting patients with appropriate treatment. Health authorities may also assess whether close contacts need screening or preventive treatment.
These measures need to be designed in ways that protect confidentiality and avoid creating additional stigma against displaced residents.
People living in camps should not be portrayed as responsible for disease transmission. Displacement often places families in difficult conditions beyond their control, and the appropriate response is to provide services and improve living conditions wherever possible.
Public health teams can work with camp managers, community representatives and humanitarian organisations to provide information, identify people who need assessment and ensure that patients can continue treatment when their circumstances change.
Where a person diagnosed with TB moves to another location, coordination between health facilities can help prevent interruptions in care.
The announcement from Plateau State makes clear that outreach to displacement camps is part of the programme's response. The scale and results of those activities, including how many people are screened and how many complete the treatment pathway, will be important measures of progress.
Medicine shortages raise concerns about continuity of treatment
Alongside the challenge of finding patients, Bot raised concerns about shortages of anti-tuberculosis medicines.
He attributed gaps in availability partly to supply-chain disruptions and the programme's dependence on international support, particularly funding from the Global Fund. The statement identifies a concern about access to medicines, but the available reports do not provide a complete inventory of the drugs affected, the duration of shortages or the number of patients whose treatment has been interrupted.
Those details would be needed to assess the precise scale of the problem.
Nevertheless, medicine availability is central to tuberculosis control. Patients need access to the appropriate drugs for their diagnosed condition, and treatment must be managed according to clinical guidance.
TB disease is generally treated with a combination of antibiotics over a period of months. The specific regimen and duration depend on the type of disease, the patient's circumstances and whether the bacteria are resistant to particular medicines.
The WHO warns that stopping treatment prematurely or taking medicines incorrectly can contribute to treatment failure and the development of drug resistance. Patients should therefore follow the treatment plan prescribed by their health professionals and seek advice if they experience difficulties. (WHO tuberculosis fact sheet)
A shortage can create difficulties for patients and health services if the medicines required for a prescribed regimen are not available when needed. The response must ensure that patients receive appropriate guidance from their healthcare providers rather than attempting to modify treatment on their own.
The state programme's concern points to the importance of procurement planning, stock monitoring, reliable distribution and coordination between government agencies and funding partners.
If a supply disruption is identified early, health authorities may have more time to coordinate deliveries and reduce the risk of patients being left without the medicines they need.
Transparent information about stock levels and distribution challenges would help establish whether the reported shortages are localised or more widespread and what action is required to address them.
Why completing treatment matters
Tuberculosis treatment is not simply a matter of taking medication for a few days until symptoms improve.
The bacteria can persist even when a patient begins to feel better, which is why treatment needs to follow the schedule prescribed by the healthcare team.
For many forms of drug-susceptible TB, the standard treatment course lasts several months. The WHO identifies commonly used medicines including rifampicin, isoniazid, pyrazinamide and ethambutol, while noting that the appropriate regimen depends on the patient's clinical circumstances. Some drug-resistant forms require different treatment approaches. (WHO tuberculosis fact sheet)
Patients should not stop, skip or change medicines without professional advice. Anyone experiencing side effects or difficulties obtaining medication should contact the treating facility as soon as possible so that the situation can be assessed.
Support from health workers, trained volunteers and family members, where appropriate and with the patient's consent, can help patients remain connected to care.
For people whose lives have been disrupted by displacement, transport costs, relocation and uncertainty about where to obtain medication can make treatment more difficult. Services that take these barriers into account may help patients continue care even when their living arrangements change.
The Plateau programme's focus on outreach and linking people to treatment is therefore important, but the long-term result will depend on whether patients can continue receiving the medicines and support required.
Monitoring treatment completion, missed appointments and medicine availability can help health authorities identify problems before they lead to worse outcomes.
Who faces a greater risk of serious illness?
Bot identified malnutrition, advanced age, weakened immunity, overcrowding and HIV infection among factors that can increase the risk of tuberculosis infection or severe illness.
The WHO also identifies conditions such as undernutrition, diabetes, tobacco use and a weakened immune system as factors associated with a higher risk of developing active TB disease. People living with HIV face a particularly increased risk because their immune systems may be less able to contain the bacteria. (WHO tuberculosis fact sheet)
These factors do not mean that a person will inevitably develop tuberculosis. They indicate why certain people may need particular attention in screening and prevention programmes.
Children, older adults and people with weakened immunity may require careful assessment when exposed to TB or when symptoms appear. Health professionals can advise on appropriate testing and whether preventive treatment is indicated.
Undernutrition can also affect overall health and make recovery from illness more difficult. In communities facing displacement or food insecurity, access to adequate nutrition may be an important part of a broader public health response.
Services that integrate TB screening with other appropriate health interventions can help identify overlapping needs. For example, health facilities may assess eligible patients for HIV and other conditions in accordance with national guidance and the patient's consent.
The key is to ensure that people receive confidential, non-discriminatory care based on their individual needs.
How community-led monitoring can help
The Plateau announcement was made at a media advocacy meeting on community-led monitoring under the Global Fund AIDS, Tuberculosis and Malaria Integrated Community-Led Monitoring Project.
Peter Ezekiel, the Plateau State programme officer for the project, said community-led monitoring was designed to involve residents and other stakeholders in identifying gaps in healthcare delivery and advocating improvements.
According to the report by Premium Times, he said the approach could help communities identify barriers such as stigma, discrimination and gender-related challenges, while advocating better infrastructure and increased domestic funding for health services. (Premium Times)
The project also reported a number of community-supported interventions in primary healthcare facilities across Plateau State.
These included the rehabilitation and re-piping of toilet facilities at the Primary Health Centre in Rantya, Jos South; the donation of a scanning machine and 10 iron-framed chairs to the Primary Health Centre in Gangare, Jos North; and the provision of a blood pressure monitoring device to the facility in Dogon Agogo.
Other reported contributions included hospital bed mattresses for the Primary Health Centre in Pushit, Mangu, and sputum collection cups for the COCIN Rehabilitation Centre in Mangu. Community members also provided 500 patient enrolment forms to support healthcare delivery.
These interventions were reported by the project and should be understood as examples of local contributions rather than a complete assessment of healthcare conditions across the state.
Community-led monitoring can help identify practical problems that may not be fully captured in routine administrative reports. Residents may be able to point to unavailable supplies, damaged facilities, disrespectful treatment, barriers to access or gaps in information that affect their experience of care.
For the process to improve health services, identified problems need to be documented, discussed with responsible authorities and followed through to resolution.
The participation of communities can strengthen accountability, but it does not remove the responsibility of government to provide properly funded and staffed health services.
The need for reliable primary healthcare
Primary healthcare facilities often provide the first point of contact for people seeking assessment and treatment.
For tuberculosis, they can help identify symptoms, arrange appropriate testing, connect patients with treatment services and provide information about preventing transmission.
Their effectiveness depends on the availability of trained personnel, diagnostic resources, essential medicines, reliable referral pathways and facilities that patients can reach.
The reported community contributions in Plateau show how local stakeholders can help address some immediate gaps. However, donations and community initiatives should complement, rather than replace, sustained public investment and reliable supply systems.
Facilities need regular maintenance, adequate staffing and access to the resources required to deliver services consistently.
For TB programmes, coordination between community outreach teams, primary healthcare centres, laboratories and treatment providers is particularly important. A patient identified during an outreach exercise must be able to complete testing and receive the appropriate treatment without unnecessary delays.
Where patients live far from a facility or face financial barriers, local outreach and follow-up can help connect them with care.
Health authorities can also use monitoring data to identify areas where screening or treatment services are not reaching enough people.
The Plateau figures provide a reason to examine how effectively services are reaching communities with high estimated needs, including areas affected by displacement.
A sustained response would require collaboration between state health authorities, local governments, health facilities, community organisations and external partners, alongside reliable funding and public reporting of progress.
Nigeria's wider tuberculosis challenge
Plateau State's estimated burden is part of a much larger national and global public health challenge.
The WHO's 2025 Global Tuberculosis Report identifies Nigeria among the countries accounting for a substantial share of global TB illness. The report estimated that 10.7 million people fell ill with tuberculosis worldwide in 2024, including 1.2 million children, while 1.23 million people died from the disease. (WHO Global Tuberculosis Report 2025 fact sheet)
These global figures underline why finding people with the disease, ensuring access to diagnosis and maintaining treatment are central to public health efforts.
Nigeria's national response involves disease surveillance, diagnostic services, treatment delivery and prevention programmes. The Nigeria Centre for Disease Control and Prevention publishes situation reports on several infectious diseases, including tuberculosis, while other health authorities and implementing partners support TB-related services. (NCDC disease situation reports)
The effectiveness of these efforts depends on how well services reach people in different settings, including urban communities, rural areas, displacement camps and correctional facilities.
In places affected by insecurity, health workers may face additional difficulties reaching patients and maintaining consistent services. These challenges can require flexible approaches, stronger coordination and additional support for frontline personnel.
The Plateau announcement is therefore relevant beyond the state's boundaries. It illustrates how national disease-control ambitions depend on local implementation and the ability to respond to conditions that affect access to care.
What residents can do
Health officials have urged residents with symptoms suggestive of tuberculosis to seek medical assessment.
People should pay attention to persistent coughs, unexplained weight loss, fever, night sweats, chest pain or other concerning symptoms and obtain advice from a qualified healthcare professional.
Anyone who has had close contact with a person diagnosed with TB, or who believes they may be at increased risk, can ask a health worker whether screening is appropriate.
People diagnosed with tuberculosis should follow the treatment plan provided by their healthcare team. They should not stop or change medicines without professional guidance, even if symptoms improve or they encounter difficulties with the treatment.
If medicines are unavailable at a facility, patients should ask the treating health worker for instructions on how to proceed rather than attempting to substitute drugs or adjust doses themselves.
Appropriate respiratory hygiene can also help reduce exposure. People with suspected or confirmed infectious pulmonary TB should follow advice from health professionals, including guidance on ventilation, cough etiquette, masking where recommended and limiting exposure to others during the period advised by their care team.
Communities can help by sharing accurate information, avoiding discrimination and encouraging people with symptoms to seek care promptly.
These actions cannot replace the responsibility of public authorities to provide accessible testing, medicines and treatment services. They can, however, support the broader effort to identify disease earlier and reduce preventable transmission.
What should happen next?
The immediate priorities arising from the Plateau announcement include maintaining access to anti-TB medicines, expanding case detection and ensuring that patients identified through screening can complete the treatment process.
The reported shortages require clearer information about which medicines are affected, where supply gaps are occurring and what steps are being taken to restore reliable availability. Such details would help the public understand the extent of the challenge and assess the adequacy of the response.
The programme's outreach in displacement camps and correctional centres also warrants continued attention. Useful indicators would include the number of people screened, the number referred for diagnostic testing, the number confirmed to have TB, the number starting treatment and the proportion able to complete the prescribed course.
Publishing such information over time could help distinguish between the number of people reached through screening and the broader estimated burden of disease.
It would also help assess whether services are reaching communities where insecurity, overcrowding and limited access to healthcare may create additional obstacles.
Community-led monitoring can contribute by identifying barriers experienced by patients and tracking whether commitments to improve services result in practical changes.
At the same time, sustained government funding and coordination with partners will be necessary to support staffing, diagnostic capacity, medicine procurement and follow-up.
The 11,000 estimate gives Plateau State a clear reason to intensify efforts, but success will depend on whether the health system can find people who need care, provide appropriate treatment and maintain support until the treatment process is completed.
Conclusion
Plateau State's estimated tuberculosis burden of about 11,000 cases in 2026, alongside 2,047 patients identified and placed on treatment between July and September, highlights the continuing challenge of controlling a disease that is both preventable and curable.
The state's tuberculosis programme has identified several obstacles, including stigma, misinformation, insecurity, population displacement, overcrowded living conditions and shortages of anti-TB medicines. These factors can delay diagnosis, complicate treatment and make it harder for health workers to reach vulnerable communities.
The programme's focus on outreach and active screening in displacement camps and correctional centres represents an effort to bring services closer to people who may otherwise struggle to obtain care. Community-led monitoring and local support for health facilities also offer ways to identify service gaps and encourage accountability.
However, sustained progress will require reliable access to diagnostic services and medicines, effective follow-up, public education and consistent investment in primary healthcare.
Residents should seek medical assessment for symptoms suggestive of tuberculosis, follow professional advice and avoid stigma against people affected by the disease.
The figures announced in Jos are an important warning about the scale of the challenge, but they are also a reminder that tuberculosis control is possible when communities and health services work together.
The central task for Plateau State is to turn case estimates and screening efforts into early diagnosis, uninterrupted treatment and better health outcomes for the people who need care.
Comments
Post a Comment